Description

What is Thymosin Alpha 1 (Tα1)?

Thymosin Alpha 1 (Tα1) is a synthetic polypeptide analog of thymosin, a natural protein produced by the thymus gland. The thymus is responsible for generating T cells, which play a crucial role in the proper functioning of the immune system. As we age, our bodies produce less thymosin, increasing the risk of infections, autoimmune diseases, and inflammation.

Thymosin Alpha 1 has been approved in 37 countries for the treatment of hepatitis and cancer. In clinical trials, it has been used to support immune function either as a monotherapy or in combination with standard medications. It holds strong therapeutic potential for individuals looking to strengthen their immune system or who suffer from infections or autoimmune conditions.

Benefits of Thymosin Alpha 1

• Exhibits antibacterial, antiviral, and antifungal properties
• Enhances the function of key immune cells
• Helps eliminate infected or abnormal cells and stops infections or tumor growth
• Provides protection against oxidative damage
• Effective against acute and chronic infections
• Suppresses tumor growth
• Boosts vaccine effectiveness

Product Presentation
Vial containing 10 mg of Thymosin Alpha 1

Usual Dosage

• 1.25 mg subcutaneously every 3 days until the vial is depleted
• Reconstitute with 2 ml of sterile diluent
• Administer 25 IU using an insulin syringe, subcutaneously, every 3 days

Keep refrigerated after reconstitution.